Strategic Global Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-166,856
| Closed | -$6.81M | – | 158 |
|
|
2023
Q1 | $6.81M | Sell |
166,856
-14,791
| -8% | -$639K | 1.09% | 34 |
|
|
2022
Q4 | $9.31M | Sell |
181,647
-3,383
| -2% | -$162K | 1.49% | 18 |
|
|
2022
Q3 | $8.1M | Sell |
185,030
-7,462
| -4% | -$363K | 1.35% | 22 |
|
|
2022
Q2 | $10.1M | Buy |
192,492
+109,826
| +133% | +$5.6M | 1.54% | 12 |
|
|
2022
Q1 | $4.28M | Buy |
82,666
+3,865
| +5% | +$201K | 0.63% | 57 |
|
|
2021
Q4 | $4.65M | Buy |
78,801
+6,347
| +9% | +$314K | 0.6% | 58 |
|
|
2021
Q3 | $3.12M | Buy |
72,454
+16,348
| +29% | +$724K | 0.46% | 77 |
|
|
2021
Q2 | $2.2M | Buy |
+56,106
| New | +$2.18M | 0.4% | 92 |
|
|
2020
Q4 | – | Sell |
-43,742
| Closed | -$1.52M | – | 172 |
|
|
2020
Q3 | $1.52M | Buy |
43,742
+8,489
| +24% | +$298K | 0.29% | 89 |
|
|
2020
Q2 | $1.09M | Sell |
35,253
-6,482
| -16% | -$220K | 0.23% | 101 |
|
|
2020
Q1 | $1.29M | Sell |
41,735
-4,132
| -9% | -$141K | 0.33% | 74 |
|
|
2019
Q4 | $1.71M | Sell |
45,867
-354
| -0.8% | -$12.6K | 0.35% | 75 |
|
|
2019
Q3 | $1.58M | Sell |
46,221
-68,704
| -60% | -$2.5M | 0.36% | 78 |
|
|
2019
Q2 | $4.72M | Sell |
114,925
-7,452
| -6% | -$296K | 1.01% | 25 |
|
|
2019
Q1 | $4.93M | Buy |
122,377
+34,967
| +40% | +$1.4M | 1.04% | 27 |
|
|
2018
Q4 | $3.62M | Sell |
87,410
-18,441
| -17% | -$766K | 1.29% | 12 |
|
|
2018
Q3 | $4.43M | Buy |
105,851
+9,094
| +9% | +$350K | 1.34% | 15 |
|
|
2018
Q2 | $3.26M | Hold |
96,757
| – | – | 0.83% | 30 |
|
|
2018
Q1 | $3.26M | Hold |
96,757
| – | – | 1.12% | 21 |
|
|
2017
Q4 | $3.33M | Sell |
96,757
-3,046
| -3% | -$104K | 1.08% | 20 |
|
|
2017
Q3 | $3.38M | Hold |
99,803
| – | – | 1.29% | 20 |
|
|
2017
Q2 | $3.18M | Sell |
99,803
-15,315
| -13% | -$483K | 1.17% | 22 |
|
|
2017
Q1 | $3.74M | Sell |
115,118
-80,489
| -41% | -$2.54M | 1.35% | 16 |
|
|
2016
Q4 | $6.03M | Sell |
195,607
-1,026
| -0.5% | -$31.3K | 2.24% | 7 |
|
|
2016
Q3 | $6.57M | Hold |
196,633
| – | – | 2.45% | 6 |
|
|
2016
Q2 | $6.57M | Hold |
196,633
| – | – | 2.48% | 6 |
|
|
2016
Q1 | $5.53M | Sell |
196,633
-16,885
| -8% | -$482K | 2.35% | 8 |
|
|
2015
Q4 | $6.54M | Buy |
213,518
+53,213
| +33% | +$1.67M | 2.78% | 6 |
|
|
2015
Q3 | $4.78M | Buy |
160,305
+125,516
| +361% | +$4.02M | 2.29% | 5 |
|
|
2015
Q2 | $1.11M | Buy |
34,789
+4,384
| +14% | +$143K | 0.65% | 35 |
|
|
2015
Q1 | $1M | Hold |
30,405
| – | – | 0.74% | 36 |
|
|
2014
Q4 | $899K | Buy |
+30,405
| New | +$872K | 0.8% | 39 |
|
Other funds holding PFE
Strategic Global Advisors's PFE Position: Q2 2023 in Review
Strategic Global Advisors sold out of Pfizer (PFE) in Q2 2023, closing a stake of 166,856 shares — an estimated $6.81M sold.
Strategic Global Advisors first reported a position in PFE in Q4 2014 and held it in 32 quarters. The position peaked at $10.1M in Q2 2022. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.
- Strategic Global Advisors reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
- Strategic Global Advisors sold 166,856 Pfizer shares in Q2 2023, an estimated $6.81M.
- Strategic Global Advisors first reported a position in Pfizer in Q4 2014 and held it in 32 quarters.
- Strategic Global Advisors's Pfizer position peaked at $10.1M in Q2 2022.
- 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.
Based on Strategic Global Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.